Fever News and Research

RSS

WHO urges health workers to be alert for patients exhibiting symptoms of new SARS-like virus

"The World Health Organization on Wednesday urged health workers around the world to report any patient with acute respiratory infection who may have traveled to Saudi Arabia or Qatar and been exposed to a new SARS-like virus confirmed in two people so far," Reuters reports.

27 Sep 2012

Easy steps to protect against spread of influenza

Flu season is here and Concentra is sharing some easy steps to protect against the spread of influenza, including seasonal flu vaccines available at all Concentra locations across the country. Concentra is a subsidiary of Humana Inc., one of the nation's leading health and well-being companies

27 Sep 2012

Age at onset influences juvenile dermatomyositis course

Children diagnosed with juvenile dermatomyositis at age 3 years or earlier have milder symptoms than patients with later onset, research suggests.

24 Sep 2012

Biologists unravel why some people infected with HIV have more virus

Biologists at UC San Diego have unraveled the anti-viral mechanism of a human gene that may explain why some people infected with HIV have much higher amounts of virus in their bloodstreams than others.

24 Sep 2012

NanoViricides’ oral FluCide dramatically improves survival in animals with H3N2 influenza A

NanoViricides, Inc. reported today that its oral FluCide drug candidates demonstrated dramatically improved survival in animals administered a lethal dose of the H3N2 influenza A virus.

24 Sep 2012

Global trade pressures may heighten disease incidence

The pressures of global trade may heighten disease incidence by dictating changes in land use. A boom in disease-carrying ticks and chiggers has followed the abandonment of rice cultivation in Taiwanese paddies, say ecologist Chi-Chien Kuo and colleagues, demonstrating the potential for global commodities pricing to drive the spread of infections.

24 Sep 2012

Iron transport may contribute to diabetes

Scientists have been trying to explain the causes of diabetes for many years. Researchers at the University of Copenhagen and Novo Nordisk A/S have now shown that the increased activity of one particular iron-transport protein destroys insulin-producing beta cells. In addition, the new research shows that mice without this iron transporter are protected against developing diabetes.

21 Sep 2012

FDA approves Acton’s AEROSPAN sNDA to treat asthma

Acton Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the sNDA (Supplemental New Drug Application) for AEROSPAN (flunisolide HFA, 80 mcg) Inhalation Aerosol, a hydrofluoroalkane (HFA) orally inhaled corticosteroid indicated for the maintenance treatment of asthma as a prophylactic therapy in adult and pediatric patients 6 years of age and older.

21 Sep 2012

Antiwasting supplements provide moderate improvements in child health

Study results show that ready-to-use supplementary food, provided to children at risk for malnutrition as part of a general food distribution program, does not significantly improve child weight.

20 Sep 2012

Health experts warn of linkages between climate change, increased malnutrition

"Malnutrition is likely to be the most serious health threat linked to climate shifts in the coming decades, as farmers struggle to cope with more unpredictable weather, ... epidemiologist Kris Ebi warned during a recent World Health Organization (WHO) briefing on adapting health systems to climate shifts," AlertNet reports.

20 Sep 2012

Number of recorded dengue cases up 36% over last year in Costa Rica

"A total of 8,480 people have been affected by dengue fever in Costa Rica" so far this year, representing an increase of 36 percent, or 2,230 more cases than during the same period last year, according to a Ministry of Health report, Xinhua News reports.

19 Sep 2012

AACR International Conference on Frontiers in Cancer Prevention Research to be held from Oct. 16-19

The 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research will bring together scientists, survivors and patient advocates to share the latest science on cancer prevention.

18 Sep 2012

Compelling data from two ITS Flunisyn Phase I clinical trials against multiple strains of influenza A

Immune Targeting Systems Limited, an emerging leader in the development of vaccines that promote T-cell responses against viruses and cancers, today announces compelling data from two Phase I clinical trials of FlunisynTM, the Company's lead vaccine programme which elicits potent immune responses against multiple strains of influenza-A virus.

18 Sep 2012

FDA clears Meridian Bioscience’s new illumigene Group A Strep test

Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received FDA clearance for a new molecular diagnostic test for Group A Streptococcus on the illumigene platform.

18 Sep 2012

Orthopedists should suspect necrotizing fasciitis in patients with out of proportion pain

Dr. Russell Russo, an Orthopedic Surgeon at LSU Health Sciences Center New Orleans, and other researchers stress that orthopedists should have a high index of suspicion for necrotizing fasciitis, or flesh-eating bacterial infection, in every patient with pain or other symptoms that are out of proportion to the initial diagnosis. Their recommendations are published in the September 2012 issue of Orthopedics Today.

17 Sep 2012

New test to assess viral load of cytomegalovirus

Roche announced today the commercial availability of a new test to assess a patient's viral load of cytomegalovirus (CMV). Physicians use information from the test to help them manage patients who have been diagnosed with CMV disease, specifically patients with an immune system that has been suppressed for solid organ transplantation.

From Roche Sequencing and Life Science 17 Sep 2012

Ebola outbreak in DRC responsible for as many as 31 deaths, according to revised count

"An outbreak of Ebola hemorrhagic fever has claimed possibly as many as 31 lives in the northeast of the Democratic Republic of Congo since May, Health Minister Felix Kabange Numbi said Thursday," Agence France-Presse reports.

15 Sep 2012

Clinical trial results signal 'promise, unresolved challenges' in finding effective dengue vaccine

The first-ever results from a dengue virus vaccine clinical trial aimed at showing effectiveness "provide signals rather than definitive answers, and a mixture of both promise and unresolved challenges," Orin Levine, executive director of the International Vaccine Access Center, and Ciro de Quadros, executive vice president of the Sabin Vaccine Institute, write in the Huffington Post "Impact" blog.

14 Sep 2012

Leading dengue fever vaccine candidate 30% effective in first large clinical trial

"The leading candidate to become the world's first vaccine against dengue fever was only 30 percent effective in its first large clinical trial, dealing at least a temporary setback to efforts to control a disease that threatens half the world's population," the New York Times reports.

12 Sep 2012

Positive results from Santarus rifamycin SV MMX Phase III study on travelers' diarrhea

Santarus, Inc. today announced that its Phase III clinical study to evaluate the safety and efficacy of the investigational drug, rifamycin SV MMX, met the primary endpoint of reducing time to last unformed stool (TLUS) in patients with travelers' diarrhea.

12 Sep 2012

Fever News and Research

WHO urges health workers to be alert for patients exhibiting symptoms of new SARS-like virus

Easy steps to protect against spread of influenza

Age at onset influences juvenile dermatomyositis course

Biologists unravel why some people infected with HIV have more virus

NanoViricides’ oral FluCide dramatically improves survival in animals with H3N2 influenza A

Global trade pressures may heighten disease incidence

Iron transport may contribute to diabetes

FDA approves Acton’s AEROSPAN sNDA to treat asthma

Antiwasting supplements provide moderate improvements in child health

Health experts warn of linkages between climate change, increased malnutrition

Number of recorded dengue cases up 36% over last year in Costa Rica

AACR International Conference on Frontiers in Cancer Prevention Research to be held from Oct. 16-19

Compelling data from two ITS Flunisyn Phase I clinical trials against multiple strains of influenza A

FDA clears Meridian Bioscience’s new illumigene Group A Strep test

Orthopedists should suspect necrotizing fasciitis in patients with out of proportion pain

New test to assess viral load of cytomegalovirus

Ebola outbreak in DRC responsible for as many as 31 deaths, according to revised count

Clinical trial results signal 'promise, unresolved challenges' in finding effective dengue vaccine

Leading dengue fever vaccine candidate 30% effective in first large clinical trial

Positive results from Santarus rifamycin SV MMX Phase III study on travelers' diarrhea

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News